Insider Transactions in Q4 2022 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
292,856
-48.16%
|
$27,235,608
$93.19 P/Share
|
|
Dec 15
2022
|
Thomas M Moriarty EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
137,466
-9.95%
|
$13,471,668
$98.32 P/Share
|
|
Dec 15
2022
|
Thomas M Moriarty EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
137,466
+8.91%
|
$9,622,620
$70.13 P/Share
|
|
Dec 01
2022
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.58%
|
$15,453
$101.65 P/Share
|
|
Nov 29
2022
|
Sreekanth K Chaguturu EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
442
-13.24%
|
$44,200
$100.88 P/Share
|
|
Nov 17
2022
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
131
+0.7%
|
$12,314
$94.93 P/Share
|
|
Nov 17
2022
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,323
+4.38%
|
$124,362
$94.93 P/Share
|
|
Nov 17
2022
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,323
+40.46%
|
$124,362
$94.93 P/Share
|
|
Nov 17
2022
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+5.09%
|
$131,788
$94.93 P/Share
|
|
Nov 17
2022
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,428
+16.32%
|
$134,232
$94.93 P/Share
|
|
Nov 17
2022
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+33.28%
|
$131,788
$94.93 P/Share
|